Home › Funds › Laurion Capital Management LP › IMUX

Laurion Capital Management LP position in IMUX

IMMUNIC INC · Health Care

Laurion Capital Management LP reported holding 610,326 shares of IMUX (IMMUNIC INC) in its Q2 2026 13F filing — a position valued at US$9.4M, representing 0.52% of its reported portfolio and ranking #38 among its reported holdings. Laurion Capital Management LP has disclosed IMUX holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)610.33K sh
Reported value held$9.38M
Portfolio Weight0.52%
First reportedQ1 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Laurion Capital Management LP's IMUX position evolved

Laurion Capital Management LP first disclosed a stake in IMUX in Q1 2025 at 228,431 shares (US$249K). The position peaked in Q2 2026 at 610,326 shares, worth US$9.4M. Across 6 filings, Laurion Capital Management LP increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 610,326 shares valued at US$9.4M — a reduction of -3,271,836 shares quarter over quarter.. Notable position changes include a 734% increase in Q2 2025 (shares rose 26% over the following quarter), a 106% increase in Q4 2025 (shares rose 108% over the following quarter), a 84% trim in Q2 2026 (shares fell 39% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 228.43K $248.99K New
Q2 2025 1.91M $1.33M Add
Q3 2025 1.88M $1.66M Reduce
Q4 2025 3.88M $2.07M Add
Q1 2026 3.88M $4.31M Hold
Q2 2026 610.33K $9.38M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMUX and 13F data

IMUX (IMMUNIC INC) is a Health Care company. 37 other funds we track also report a position in IMUX — the largest reported positions include BVF INC/IL (US$11.8M), Avidity Partners Management LP (US$10.3M), Jones Hill Capital LP (US$8.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMUX

All IMUX fund holders →

FAQ

How long has Laurion Capital Management LP held IMUX?

Laurion Capital Management LP has disclosed IMUX holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Laurion Capital Management LP's current position in IMUX?

As of Q2 2026, Laurion Capital Management LP holds 610.33K shares of IMUX (IMMUNIC INC), valued at $9.38M, representing 0.52% of its reported portfolio and ranking #38.

Has Laurion Capital Management LP been buying or selling IMUX?

In the latest 13F filing (Q2 2026), Laurion Capital Management LP reduced its position in IMUX. The position peaked in Q2 2026 at 610.33K shares.

Which other funds hold IMUX?

Other major institutional holders of IMUX include BVF INC/IL, Avidity Partners Management LP, Jones Hill Capital LP, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.